Category: Blood Diseases
Blood Diseases market research reports by GlobalData
-
Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update Summary GlobalData's Medical Devices sector report, “Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and C ... Read More
-
Cell and Gene Therapies in Hemophilia A & B
Cell and Gene Therapies in Hemophilia A & B Summary Clients will gain insight into the competitive landscape of leading CGT agents in Hemophilia A & B including launch date projections, key clinical trial analysis, analyst consensus forecasts, likelihood of approval analysis, and commentary on curre ... Read More
-
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024
Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) - Global Clinical Trials Review, 2024 provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report pro ... Read More
-
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032 Summary The prevalence of vWD is increasing at a steady rate, in line with population growth in the 3MM, at an AGR of 0.61%. Currently, the treatment regime ... Read More
-
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ITP therapeutics. There will be more than 1.6 million diagnosed prevalent cases of I ... Read More
-
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Thalassemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Typ ... Read More
-
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hemophilia B (Factor IX Deficiency) Clinical Trial Analysis by Trial Phase, Trial Stat ... Read More
Research Assistance
